Advertisement
Entire Site
Articles/Fact Sheets
Ask the Experts
Conference Coverage
Library of Older Articles
HIV/AIDS Basics & Prevention
HIV/AIDS Basics & Prevention
Basics & Prevention: Home
HIV/AIDS Basics
HIV Prevention
HIV Testing
Who Gets HIV/AIDS?
Myths About HIV/AIDS
More ...
Just Diagnosed
Just Diagnosed
Just Diagnosed: Home
Choosing a Physician
Coping
HIV Hotlines & Orgs
Telling Others
More ...
HIV Treatment
HIV Treatment
HIV Treatment: Home
Drug Resistance
HIV Medications
Side Effects & Health Problems
Starting Treatment
Women & Pregnancy
More ...
Living With HIV
Living With HIV
Living With HIV: Home
Arts & Entertainment
Beyond Medications
Inspiring Stories
Mental Health
More ...
AIDS Policy & Activism
AIDS Policy & Activism
HIV Policy & Activism: Home
Activist Central
Medicine Recycling
U.S.-Specific News
Developing World News
More ...
HIV Around the World
HIV Around the World
HIV Around the World: Home
Africa
Asia
Latin America
U.S. and Canada
Western Europe
More ...
Conference Coverage
Conference Coverage
Conference Coverage: Home
CROI 2009
ICAAC/IDSA 2008
Previous Conferences
Upcoming Conferences
More ...
E-Mail
Glossary
Share
Hivid (Zalcitabine, ddC)
See also:
Drug Interactions
|
Medication Side Effects
|
All HIV Medications
Show Archived (Historical) Articles
Brand Name:
Hivid
Generic Name:
Zalcitabine, ddC
Adult Single Dose:
One 0.75-mg tablet (every 8 hours)
Food & Liquid Restrictions:
Take on an empty stomach
Drug Class:
NRTI
An Overview of Hivid (Zalcitabine, ddC)
(Regularly Updated)
To read PDF,
click here
.
From
U.S. National Institutes of Health
Zalcitabine (Hivid, ddC)
(November 13, 2009)
To read PDF,
click here
.
From
AIDS InfoNet
ddC (Hivid)
(August 15, 2006)
From AIDS Treatment Data Network
Patient Information About Hivid (Zalcitabine, ddC) (PDF)
(September 2002)
From Roche
E-Mail
Glossary
Share
Advertisement